Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: J Thromb Haemost. 2020 Mar 30;18(6):1278–1290. doi: 10.1111/jth.14785

Table 1. Percentage PEGylation efficacy of A1A2A3 cysteine variants and wild-type A1A2A3.

The PEGylation efficacy for each of the A1A2A3 variants as measured by analytical size exchange chromatography following PEG maleimide conjugation and purification. No conjugation of PEG to WT-A1A2A3 was observed.

A1A2A3 Variant % PEGylated species
WT A1A2A3 0
S1286C 99.3
Q1353C 90.5
M1545C 94.7
L1591C 96.1
V1636C 79.3
Q1652C 91.1
V1803C 89.8
S1807C 94.7